Wall Street Journal (subscription) | A Slow Bankruptcy Process Stops Locale-Reviving Jobs Wall Street Journal (subscription) We contacted the Rock County [Janesville] Development Alliance director to inquire about the site. We were told that we could not consider the site because it was still tied up in bankruptcy court. We then tried repeatedly to connect with Rep. Paul ... |
Visit link:
A Slow Bankruptcy Process Stops Locale-Reviving Jobs - Wall Street Journal (subscription)
New York Times | Alitalia Files for Bankruptcy, but Italy Balks at a Third Bailout New York Times But on Tuesday, even a papal decree would not have been enough to save Alitalia from what threatened to be its final stand, as Europe's most troubled airline filed for bankruptcy once more, this time amid signs that the government, and the Italian ... Alitalia Declares BankruptcyAgain Alitalia Starts Bankruptcy Process as Etihad Cuts Off Funds Alitalia kicks off bankruptcy proceedings, government grants loan |
Go here to read the rest:
Alitalia Files for Bankruptcy, but Italy Balks at a Third Bailout - New York Times
In the US, research-led sales and marketing services company Maritz has appointed Charlotte Blank as Chief Behavioral Officer (CBO), tasked with leading its thought leadership, research, and the application of behavioral science.
The firm is based in St. Louis and its portfolio of services includes market and customer research; customer loyalty, sales incentives, employee rewards and recognition programs; and meeting, event and travel incentive services. Blank (pictured) previously led neuromarketing, social media and global branding initiatives during her ten years in the media and automotive industries, which included stints at Turner Broadcasting and General Motors. In her new role, she will also develop Maritz' network of academic partners and focus on opportunities for field research with these contacts and with clients.
CEO and Chairman Steve Maritz comments: 'At our core, we're a behavior company. The scientific study of human behavior is a central component of Maritz' DNA, and ingrained in the design of our client solutions. With Charlotte as our CBO, we can emphasize to the market and our clients the role behavioral science plays in powering our solutions and improving their business performance'.
Web site: http://www.maritz.com .
See more here:
Maritz Hires Chief Behavioral Officer - Daily Research News Online
Recent research, led by assistant professor of stem cell biology and regenerative medicine at the University of South Carolina Joseph T. Rodgers, has found a way to increase the bodys ability to heal after injury. The study was published in the scientific journal Cell Reports.
The research was funded by grants from the National Institutes of Health. Funding was also secured from the Donald E. and Delia B. Baxter Foundation, Glenn Foundation for Medical Research, and the Department of Veterans Affairs. The study was co-sponsored by the Department of Neurology and Neurological Sciences at Stanford. Clinical Research
In previous research, Rodgers proved that adult stem cells enter an alert state when the body sustains an injury. Alert stem cells have greater ability to heal and repair damaged tissues.
Rodgers theorized that blood from an injured person could produce a state of alert in another persons stem cells. Using lab mice, he and his team injected healthy mice with blood from their injured counterparts. The stem cells of the healthy mice were observed to adopt the state of alert.
The team was able to expose the chemical mechanism used to signal cells to enter an alert state as the enzyme Hepatocyte Growth Factor Activator (HGFA). HGFA is always present in the bloodstream but does not activate until the body experiences an injury. Once an injury occurs, the enzyme signals adult stem cells to enter the alert state.
Implications for Repair Response in the Injured Body
Once these findings were discovered, Rodgers team decided to investigate what would happen if an injury was sustained while the adult stem cells were already in a state of alert.
HGFA was injected into healthy mice. Several days later, the mice were given skin or muscle injuries. Test subjects were observed to heal faster, regrow missing fur, and return to running on exercise wheels sooner.
This research supports the idea that the presence of HGFA in the bloodstream prepares the body to respond more quickly and efficiently to injury. Similar to the way vaccines prepare the body to fight specific diseases, HGFA readies cells to respond to tissue damage.
Future Applications
In the future, people may be able to use HGFA before they engage in activities that could result in injury, like sports, surgery, or battle. HGFA could also be used in a therapeutic capacity for those with compromised healing abilities, like diabetes patients or senior citizens.
Forthcoming studies will explore how HGFA affects declines in the ability to heal, and how to use it to restore normal healing abilities.
Read the original here:
Triggering Stem Cells for Accelerated Healing - Anti Aging News
For caucasians, it's wrinkles and age spots
Juta/Shutterstock"My caucasian patients tend to commonly present in their early 30s with wrinklesparticularly around the eyes or glabella (between the eyebrows)," says board certified dermatologist Manjula Jegasothy, MD, founder of Miami Skin Institute, who has been treating ethnically diverse patients for 20 years. "This is easily treated with Botox in the 30s and early 40s." She also suggests adding light radiofrequency treatments in the mid to late 40s to help with thin skin laxity in the upper face. Sun damageresulting in brown spots and blotchinessis another common complaint. She suggests getting a jump start in the early 20s and 30s with pyruvic, salicylic, and glycolic acid peels. Try: Dr. Dennis Gross Skincare Alpha Beta Universal Daily Peel and BeautyRx by Dr. Schultz Advanced 10% Exfoliating Pads. Patients in their late 30s and olderand those with more severe damageshould consider in-office IPL photofacials. This is how your skin ages through every decade of your life.
Click-Images/ShutterstockThe majority of Dr. Jegasothy's patients are Latina, and the culture is very focused on body image. "I find that these patients are much more focused on non-surgical treatment of scars," Dr. Jegasothy says. For best results, scars should be treated as soon as possiblewithin the first two years; ideally as early as three weeks after the incision has healedwith a combination of Vbeam and Fraxel laser. Since Miami is a city with warm temperatures year round, her Latin American patients tend to be more concerned with skin laxity issues and celluliteparticularly on the thighs and buttocks, the areas that show in shorts. For both of these issues, Dr. Jegasothy recommends radiofrequency treatments with the Viora laser. Ever wondered why is cellulite so dang hard to get rid of?
Content continues below ad
Dragon-Images/Shutterstock"My AsianChinese, Japanese, and Koreanpatients are interesting because they are very concerned with trying to become an idealized version of a caucasian with features common in the Asian press," says Dr. Jegasothy. As such, the most common Botox procedure she performs on her Asian patients is softening the jawline muscle to create a more oval or round appearance. Another common beauty request of her Asian patients is for their facial skin to be as fair as possible. To this end, she does skin lightening chemical peels and topical herbal agents, such as SkinMedica Lytera 2.0 Pigment Correcting Serum as often as possible."
Prostock-studio/Shutterstock"I have been treating Indian patients for over 20 years, and by far the most common complaint is excessive hair on the face and body," notes Dr. Jegasothy. She stresses the importance of using the correct lasers and settings for the various skin tones, since those that are too strong can cause hyperpigmentation that can persist for up to a year. Her preference is the Candela GentleYag Laser. (Don't miss the 14 things you need to know before you get laser hair removal.) The second most common issue is dark under-eye circles. When patients are young, this can be successfully treated with mild cortisone creams and peptide eye creams, such as Neocutis Micro-Eyes. "As patients age, if they have hollowing along the orbital bone (which is the lower eyelid rim), and filler can make the under-eye circle seem less prominent." More often however, she finds that light Fraxel treatments (repeated every four to 12 months, depending on severity, genetics and age), can improve this situation enormously. These are the secrets to aging gracefully.
sruilk/ShutterstockAccording to Dr. Jegasothy, Middle Eastern patients primarily have the same issues as Indian patients: excess hair at an early age and dark under eye circles, which are treated in the same fashion. "In addition, Middle Eastern mores dictate that patients have a certain eyebrow type, which is quite plucked at an early age. As the trend today is toward fuller brows, I'm seeing more Middle Eastern patients in early to middle age who are looking for more eyebrow hair." For this, she recommends Latisse, a topical hair-growth serum available by prescription. Find out the best brows for your face shape.
Content continues below ad
Continued here:
Subscribe to Print: - Reader's Digest
(MENAFN Editorial) Hermann Wellness, an anti-aging treatment medical spa with locations in Tampa and St. Petersburg, recently launched its newly redesigned and restructured website at http://doctorhermann.com.
Hermann Wellness, led by Dr. Anne Hermann, M.D., provides the best and most comprehensive aesthetic medicine services in the Tampa Bay area. It is Dr. Hermann's mission to enable each of her patients to achieve optimal health by combining cutting edge technology and the latest research with compassionate medical care. Now, Hermann Wellness offers visitors and patients an updated and redesigned website for an enhanced browsing experience.
The newly designed Hermann Wellness website, found at http://doctorhermann.com, offers users a comprehensive menu with detailed information about each of the more than 50 services that Dr. Hermann has to offer. This interactive site also offers informative videos from Dr. Hermann herself, an online scheduling tool, and reviews from past patients. Overall, the new design and fresh content highlight the true impact that Dr. Hermann and her team can make to improve her patient's overall health offering treatments that address overall wellness and beauty from the inside out.
Dr. Hermann has more than 17 years of experience in internal, holistic, and cosmetic medicine. She obtained her Board Certification in Internal Medicine in 2000, then trained as a medical acupuncturist at UCLA Medical School and Professional Hypnologist at the Cord Institute of Hypnosis in 2004. Dr. Hermann also became Board Certified as a Physician Nutrition Specialist in 2004. Since then, she has completed advanced training in botox, dermal fillers, and other cosmetic procedures, and she has continued to grow her expertise within the holistic approach to medicine.
With two locations in Tampa and St. Petersburg, Hermann Wellness is conveniently located for all patients seeking customized care for aesthetic treatments, weight loss services, integrative medicine, and much more. Dr. Hermann's extensive training and experience in aesthetics and weight loss has made Hermann Wellness Tampa Bay's leader in cosmetic services and physician assisted weight loss and nutrition.
Anti-aging PRP injections, dermal fillers, and micro-needling skin resurfacing to the Optifast weight loss plan and Detox Diet, Hermann Wellness offers all of the essential services that help patients achieve the health and confidence they have always wanted.
Members of the community or media interested in learning more about Hermann Wellness and its newly designed website are invited to use the following contact information:
NAME: Dr. Anne Hermann, M.D. ADDRESS: 3040 W. Cypress St., Suite 103, Tampa, FL 33609 or 6387 Central Ave, St. Petersburg, FL 33710 PHONE: (813) 902-9559 (Tampa) or (727) 278-3992 (St. Petersburg) WEBSITE: http://doctorhermann.com EMAIL:
Go here to see the original:
Hermann Wellness of Tampa and St. Petersburg Launches Newly Designed Website - MENAFN.COM
ST. LOUIS--(BUSINESS WIRE)--
Maritz announced today the appointment of Charlotte Blank to chief behavioral officer (CBO) of the company. In this new role, Blank will lead the companys thought leadership, research and application of behavioral science. Maritz joins a growing population of progressive businesses dedicating a c-suite executive to behavioral science in business.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170428006071/en/
At our core, were a behavior company. The scientific study of human behavior is a central component of Maritz DNA, and ingrained in the design of our client solutions, said Steve Maritz, chairman and CEO of Maritz. Our expertise in this space has grown tremendously over the years. With Charlotte as our CBO, we can emphasize to the market and our clients the role behavioral science plays in powering our solutions and improving their business performance.
As Maritz CBO, Blank will forge the connection between academic theory and applied business practice, elevating the use of field research to propel Maritz people solutions and client programs. Her responsibilities will include growing Maritz network of world-class academic partners and focusing on opportunities for field research with these academics and clients.
Maritz has always been a leader in understanding, enabling, and motivating behavior, said Charlotte Blank, newly appointed chief behavioral officer of Maritz. Its exciting to see us elevate the study of behavioral science as the foundation for our expertise in what drives people.Our clients count on us to bring them the latest human science advancements to design higher-performing programs that drive behavior and business results.
Prior to Maritz, Blank led programs in neuromarketing, social media, and global branding during herten years in the media and automotive industries, including stints at Turner Broadcasting, and General Motors. She earned a Bachelor of Science degree in Neuroscience and Behavioral Biology from Emory University, and a Master of Business Administration from Harvard Business School.
To learn more about Charlotte Blanks perspective on behavioral science in business, view a recent article here and follow Charlotte Blank on Twitter @CharlotteBlank.
About Maritz
St. Louis-based Maritz is a sales and marketing services company, which helps businesses achieve their full potential through inspiring and motivating employees, channel partners and customers. Maritz companies provide market and customer research; customer loyalty, sales incentives and employee rewards and recognition programs; and meeting, event and travel incentive services to Fortune 500 companies and beyond. For more information, visit maritz.com or contact us at 1-877-4MARITZ.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170428006071/en/
MULTIMEDIA AVAILABLE:http://www.businesswire.com/news/home/20170428006071/en/
Read the original post:
Maritz Appoints Chief Behavioral Officer (CBO), Charlotte Blank - Yahoo Finance
ASU plans master's in athletic training
Arkansas State University will start its new master's degree program in athletic training.
The Jonesboro campus currently offers a Bachelor of Science degree in athletic training, which is housed under the College of Education and Behavioral Science, but will phase that out. The new master's program -- which is now only offered by the University of Arkansas, Fayetteville -- will be under Arkansas State's College of Nursing and Health Professions.
The university plans to hire one faculty member by July 1, 2018, for the new program.
The Arkansas Higher Education Coordinating Board approved the new master's program earlier this month. About 70 percent of certified athletic trainers have a master's degree, according to the National Athletic Trainers' Association.
Arkansas State anticipates 12 students to enroll in the program starting in the summer of 2018. Applicants must have a bachelor's degree in no particular field of study, but the university said required classes in some fields -- including biology and exercise science -- are more aligned with the master program's prerequisite requirements.
UCA, 2 colleges join in degree program
The University of Central Arkansas has partnered with two community colleges to help students finish a bachelor's degree in elementary or middle-level education.
The Conway university has created "2+2" agreements with North Arkansas College in Harrison and Northwest Arkansas Community College in Bentonville for the programs.
Students who have completed an associate of science in education at North Arkansas or an associate of science in liberal arts and sciences at Northwest Arkansas are eligible for the transfer program. Students must be accepted into UCA and into UCA's Teacher Education program, must show proof of minimum ACT or SAT college entrance exams and must have a cumulative grade-point average of at least 2.7.
North Arkansas will have to develop two courses, one in earth science and another in exceptional child, and will have to retool its child growth and development course, according to the agreement. Northwest Arkansas will have to add an earth science course.
The agreement will be in effect this fall, and any student currently attending either institution can start at any time, as long as he meets the requirements.
Metro on 04/29/2017
Print Headline: ASU plans master's in athletic training UCA, 2 colleges join in degree program
Continue reading here:
Higher education notebook - Arkansas Online
Researchers in India report that yoga postures, breathing disciplines and meditation may be the key to prolonging that proverbial fountain of youth. Biomarkers found in human blood samples drawn during a clinical trial showed the anti-aging benefits of practicing these ancient holistic practices.
In the Yoga and Meditation Based Lifestyle Intervention (YMLI) clinical trial, scientists enrolled a homogenous, seemingly healthy group of 96 men and women aged 30-65 years old, who had not experienced any significant lifestyle or physical challenges over the preceding three months between August 2015 and May 2016. Once enrolled, participants had 5 milliliters of fasting venous blood drawn to establish baseline markers for a range of primary and secondary aging characteristics. They next practiced yoga and meditation in the 12-week program to measure the disciplines anti-aging benefits.
During the trials initial 14 days, the group received instructions from registered, specialized yoga instructors for five days each week at the AIIMS health clinic in New Delhi, India. The YMLI instructions incorporated Hatha and Raja yoga techniques including physical postures, breathing exercises and meditation into their 90-minute classes. Following yoga, a 30-minute lecture focused on the importance of a healthy lifestyle and diet in warding off conditions like cancer, diabetes and cardiovascular diseases, among others.
The participants then were required to continue their practices at home for the subsequent 10 weeks and were responsible for self-monitoring their progress in a diary or by regular telephone conversation. At the trials conclusion, another 5 milliliters venous blood was drawn to compare the pre- and post-YMLI levels of various markers.
The scientists analyzed the changes in primary and secondary aging characteristic found in participants blood before and after the 12-week program. Primary measures included DNA damage that leads to metabolic instability, oxidative stress levels, total antioxidant levels, among others. As secondary factors, they examined cortisol levels a reading of stress responsiveness inflammation and cellular plasticity, among others.
The researchers hypothesis was confirmed when they examined the trial participants blood at the end of the 12-week trial. In every instance, YMLI was associated with changes for the better, indicating a slow-down of the cellular aging process. The authors hailed their clinical trial as the first to investigate the effects of YMLI on age-related biomarkers. Almost no gender-based biomarker differences appeared in the trial. This trial serves as a springboard bringing the practice of yoga and meditation further into mainstream science surrounding aging and disease prevention.
The study is limited by its small size, homogenous population and lack of a similarly sized control group.
The trials findings were published online on Jan. 16, 2017, by Oxidative Medicine and Cellular Longevity.
So, you may want to bend and twist into a yogic position, breathe deeply and meditate in your individual quest to recapture that elusive fountain of youth.
Written By:Susan Mercer Hinrichs, MA, MBA, CPhT
Read more here:
Anti-Aging Benefits of Yoga - Medical News Bulletin
In 2013, Time magazine ran a cover story titled Google vs. Death about Calico, a then-new Google-run health venture focused on understanding aging and how to beat it. We should shoot for the things that are really, really important, so 10 or 20 years from now we have those things done, Google CEO Larry Page told Time.
But how exactly would Calico help humans live longer, healthier lives? How would it invest its vast $1.5 billion pool of money? Beyond sharing the companys ambitious mission to better understand the biology of aging and treat aging as a disease Page was vague.
I recently started poking around in Silicon Valley and talking to researchers who study aging and mortality, and discovered that four years after its launch, we still dont know what Calico is doing.
I asked everyone I could about Calico and quickly learned that its an impenetrable fortress. Among the little more than a dozen press releases Calico has put out, there were only broad descriptions of collaborations with outside labs and pharmaceutical companies most of them focused on that overwhelmingly vague mission of researching aging and associated diseases. The media contacts there didnt so much as respond to multiple requests for interviews.
People who work at Calico, Calicos outside collaborators, and even folks who were no longer with the company, stonewalled me.
We should pause for a moment to note how strange this is. One of the biggest and most profitable companies in the world has taken an interest in aging research, with about as much funding as NIHs entire budget for aging research, yet its remarkably opaque.
Google also prides itself for being a leader on transparency and for its open culture. And were living in a time when the norms in science, particularly biomedical science, are centered around openness and data sharing. But these values have somehow eluded Calico.
For now, I think its safe to say Google has not solved aging. Or if it did, they havent told anybody.
Its not unusual for new startups to be stealthy for a period while they get going, but theres usually some public statement with specific details about the technology or science being developed, strategies and targets. That Calico wont say what its doing bothers leading aging researchers. They expressed confusion or frustration about Calicos stealthiness, and said the secrecy is not productive for science.
Eric Topol is a cardiologist who studies aging and the director of Scripps Translational Science Institute. Topol knows some of the scientists at Calico from their pre-Calico days. Theyre hyper secretive, he said. Since they moved to Google, he cant seem to reach them. I have invited them to speak at our program we have on genomic medicine. They say no, they cant talk about what theyre doing. I am not sure why thats the case.
There were no clinical trials or patents filed publicly under the Calico brand that I could find, and out of the 22 papers published by the company and its affiliates, only about half related to aging and many were review articles (not original research).
Nir Barzilai, a geneticist and one of the leading researchers in aging based at Albert Einstein College of Medicine, said the publications didnt give him any special insights into what Calico is up to. Our field is interested in delaying aging and by that, delaying disease. [It seems] they are not doing that, he said. Its weird they dont come to us, look at our patents We have resources, we are eager to do partnerships and form bio-techs. And nobody from Calico talks to us.
Other top researchers on aging told me much the same. I dont interact with them, Felipe Sierra, director of the division of aging biology at NIHs National Institute on Aging, said. They dont want to interact with me. I ignore them as much as they ignore me. He also invited Calico scientists to present at NIH. They come to the meeting but they dont talk about what they are doing [They] wouldnt even talk about general directions [of their research].
There are a few potential explanations for Calicos secrecy. Among them: that Calico is just waiting for a big reveal. A December article in the MIT Technology Review, which was also scant on details about Calicos anti-aging science, hinted that might be the case:
[David] Botstein [the Calico Chief Scientific Officer] says a best case scenario is that Calico will have something profound to offer the world in 10 years. That time line explains why the company declines media interviews. There will be nothing to say for a very long time, except for some incremental scientific things. That is the problem.
But avoiding media hype does not require secrecy among scientific colleagues. If Calicos scientists were truly interested in pushing the boundaries of science, they might think about using some of the best practices that have been developed to that end: transparency, data sharing, and coordinating with other researchers so they dont go down redundant and wasteful paths.
As Topol said, Secretive research is pass. The world has moved on to fully demonstrate the value of openness, transparency, and avoidance of insular thinking.
There are other possible explanations for the stealthiness. A recent news release from Calico announced a partnership with C4 Therapeutics to work on coming up with drugs for "diseases of aging," such as cancer one of a number of drug company partnerships Calico has formed. If Calicos now focused on drug development, then a degree of secrecy might make sense. (Drug companies typically develop their products quietly to stay ahead of the competition.)
But researchers dont buy that explanation, either. The researchers [Calico] hired are using models such as yeasts, nematodes, and naked mole rats, said Barzilai. These are not the models that are relevant for drug development. Developing cures also doesnt fall in line with the companys original mission to treat aging as a genetic disease instead of hunting for treatments for age-related diseases.
Another potential reason for the lack of transparency the one I find most compelling is that its the company culture. Art Levinson, the CEO of Calico, is also chair of the board of Apple Inc. and was close to Steve Jobs, who was renowned for his clandestine approach to research and development and running a business. Its possible that Levinson has made secrecy part of Calicos DNA, the way its part of Apples DNA.
Perhaps Calico will one day justify its secrecy, Topol said. But at this point, he added, I dont understand it. Potentially withholding information about advances in biomedical science or cures for diseases is unacceptable: Lives are ultimately at stake. Anything that slows down progress in biomedical research cant be condoned.
For that reason, Id like to humbly invite Calico or people who have worked with the company to share what they are up to. I promise we wont hype it.
Have information about Calico? You can send me tips over email at julia.belluz@vox.com or secure PGP. (My key: 0AC1 64FA E095 851B 112A 0670 6D24 B5A4 56ED 285E)
Update Friday April 28, 2:34 p.m.: Thanks to reader tips and additional searches in PubMed, weve located and linked to several Calico papers we werent aware of when we first published this story on Thursday. I flagged the papers with the researchers quoted in this story who said they did not change their assessment of Calico.
See the article here:
Google is super secretive about its anti-aging research. No one knows why. - Vox
According to statistics, European womens and mens skin begin to enter into the anti-aging process at the age of 25 and 27, respectively. Anti-aging cosmeceuticals have been more and more favored in the market. Skin aging is the result of endogenous aging and exogenous aging. The initial anti-aging skin care products were mainly based on application of vitamin, such as the brand Dr. Brandt Skincare in America. At the beginning of the 21st century, extraction of active substance from plants had been widely used in the anti-aging skin care products, among which the brand SkinCeuticals was the most famous one. With the development of gene therapy and biological cell therapy technology, however, the biological cell therapy technology has been gradually applied to cosmeceuticals, among which the British brand ROSTHERNE is the representative.
ROSTHERNE is one of three main cosmeceutical brands (ROSTHERNE, HENLEAZE and VINSTRA) of EVIGT SOLSKIN COSMECEUTICALS CO., LTD. Different from the three elements of anti-aging namely precaution, protection and restoring emphasized by SkinCeuticals, ROSTHERNE focuses more on four dimensions namely restoring, fading, activation and strengthening for anti-aging research, and pays more attention to the main direction of refreshing normal physiological function of cell by human cell engineering and biomedical technology, so that youth could be continued fundamentally.
The story behind ROSTHERNE brand
ROSTHERNE brand originated from Rostherne Mere, the British National Nature Reserve and seclusion of the nobility for more than a hundred years, behind which the legend of immortal mermaid could be found. The Doctor of Medicine Jones and the aristocratic princess Ansel escaped from the manor for love and lived a displaced life. In order to make Ansel who became toilworn day by day rejuvenative, Dr. Jones came to Rostherne Mere each Easter to wait the mermaid who could give the secret of being immortal. Finally, he heard the lively bell under the water and saw rebirth of all things, so he extracted the most original anti-aging product from the native plant around the lake and let Ansel recover her youth look. They established a clinic of love to remember the mermaid with gratitude for her gift. The land around the clinic was planted with many roses, so that their love could be transmitted and the beauty could be lasting.
The anti-aging products of ROSTHERNE were developed by a group of professional dermatologists and researchers in the fields of cell, molecular biology and biophysics. And a series of effective anti-aging products were developed by them with their unique cell activation and regeneration technology as the core technology. The unique new technology of Renee Expert TM combines various plant stem cells, EGF, yeast extract, coenzyme Q10 and other anti-aging and anti-oxidation products with theory of biological cell medicine, and realizes promotion of 3D anti-aging by its superb technology. It fully activates collagen and makes the damaged skin recover its vitality.
The anti-aging effect of ROSTHERNE has been spread from England to the whole world. Today, ROSTHERNE has been introduced into America, France, Germany, Netherlands, Australia, New Zealand, Canada and Hong Kong successively. It has been increasingly praised highly by dermatologists, medical cosmetology industry and customers worldwide. ROSTHERNE constantly explores the active anti-aging elements of the ultimate effect with a rigorous scientific attitude, keeps its leading position in the anti-aging industry, and transmit Dr. Joness spirit of Sharing love, lasting beauty.
Media Contact Company Name: EVIGT SOLSKIN COSMECEUTICALS CO., LTD Contact Person: Ryan Email: Evigtsolskin@outlook.com Phone: +44?0?1428 656600 Country: United Kingdom Website: http://www.evigt-solskin.com
See the article here:
ROSTHERNE, LEAD THE MEDICAL ANTI-AGING - Press Release ... - Digital Journal
Researchers at the University of Connecticut have discovered a chemical compound that could lead to new treatments for diabetes and gastrointestinal conditions. The research team, led by Professor of Immunology and Medicine Pramod Srivastava from the University of Connecticut School of Medicine, published their official findings in the April 24 issue of the Proceedings of the National Academy of Sciences journal.
Anandamide Production
Capsaicin is a chemical compound contained in spicy chili peppers. This chemical is responsible for the sensation of heat felt when they are consumed. The chemical binds to brain receptors, called TPRV1 receptors, to signal the sensation of heat from the tongue to the brain. TPRV1 receptors are also found in the gastrointestinal tract.
As part of their research, the team administered capsaicin to lab mice. These mice were found to have less inflammation in the gastrointestinal tract. Some mice who previously showed signs of Type 1 diabetes showed normal blood sugar levels after the trials.
The results are contributed to the capsaicin binding with TPRV1 receptors in the gastrointestinal tract. The binding process prompts the receptors to produce the chemical anandamide. This chemical soothes and relaxes the gastrointestinal tract. Researchers could repeat their original results by feeding anandamide directly to the lab mice, rather than using chili peppers.
Researchers do not fully understand how the chemical causes the immune system and brain to interact.
Anandamide and cannabinoids are chemically similar. When a person consumes marijuana, anandamide receptors in the brain react to the presence of cannabinoids. This produces feelings of euphoria and relaxation, or a high. Marijuana consumption causes anandamide production.
Anandamide and the Gastrointestinal Tract
While the team has not uncovered the mechanism that allows the brain to communicate with the immune system, they do understand how it helps heal the gastrointestinal tract.
There are other receptors that react to anandamide. These signal the production of immune cells called macrophages. These cells reduce inflammation. Higher anandamide levels correlate with higher macrophage presence, which can mean a significant reduction in inflammation. Anandamide and macrophage production can positively affect conditions in the esophagus, stomach, and pancreas.
Current trials are testing the effect of anandamide on conditions affecting the lower gastrointestinal tract, such as colitis.
Future Trials
Current federal marijuana regulations make clinical trials using human subjects difficult. Researchers are hoping to partner with the state of Colorado to obtain statistics on the effect of edible marijuana on colitis sufferers. That evidence could support the use of medicinal marijuana to treat severe gastrointestinal disorders.
Future research will focus on finding the specific molecular pathway anandamide uses to send signals between the stomach and the brain. The team is also investigating how anandamide reacts with other receptors, and the functions they serve.
Nandini Acharyaa, Sasi Penukondab, Tatiana Shcheglovaa, Adam T. Hagymasia, Sreyashi Basua,1, and Pramod K. Srivastavaa,1, April 24 issue of the journal Proceedings of the National Academy of Science, Endocannabinoid system acts as a regulator of immune homeostasis in the gut, Nandini Acharya, doi: 10.1073/pnas.1612177114
See more here:
Chili Pepper and Marijuana Soothe Gut Inflammation - Anti Aging News
Japan, with its rapidly ageing population, has an obvious interest in developing regenerative medicine technology.
Bold, world-leading reform is not something usually associated with Japan or its latest policy push, Abenomics.
But there is one area where the country and its unusually long-serving Prime Minister, Shinzo Abe, can claim global leadership and that is in the field of regenerative medicine.
This relatively new area mostly involves using stem cells and the bodies own healing mechanisms to regrow cartilage or tissue and thereby avoid the need for surgery in difficult to fix areas like shoulders and hips.
Japan, with its rapidly ageing population, has an obvious interest in developing such technologies and has cleared away onerous regulation around clinical trials to kick-start the regenerative medicine industry.
"It was such a radical step," said Paul Anderson, the managing director of the ASX-listed Orthocell.
"And it has totally transformed the industry which has enabled Japan to drawn in capital and technology from around the world."
Buoyed by this success Japan is now looking to convince other countries, including Australia, on the merits its "light touch" regulation, while also looking to commercialise world-leading treatments.
That saw a delegation from the Australian industry accompany Trade Minister Steve Ciobo to Tokyo last week, where they met with Japanese regulators and companies who sold them on the benefits of commercialising their technologies in Japan.
Not that Anderson from Orthocell or John Martin, the chief executive of Regeneus - which is also listed on the ASX - needed much convincing.
"Japan wants to get in early on this revolution," said Martin.
"They are looking to hoover up all the best technologies from around the world and Australia seems to have a lot of them."
This would be a surprise to many given all the teeth gnashing around the lack of innovation in Australia. But contrary to the prevailing narrative it seems Australian companies have once again found a way to get in on the ground floor of a new, fast growing industry as the likes of Cochlear, ResMed and CSL did before them.
The ASX-listed Mesoblast, which was also on the trip to Tokyo, is the world's largest pure play stem cell company, and has had some recent success around treatments for heart failure.
Then come the likes of Orthocell, which recently did a deal with global giant Johnson & Johnson, while in December Regeneus struck a $US16.5 million agreement to license one part of its arthritis technology with Japan's AGC Asahi Glass.
The issue for Australia is that while it has a strong cluster of early stage companies in the space, the local regulatory environment is not as bold or progressive as that in Japan.
"If your regulations are too tough you stifle innovation," said Anderson from Orthocell.
And so the local industry is now pushing for Australia's Therapeutic Goods Administration to adopt the same licensing environment as Japan.
"If you asked me what I really wanted .... it would be that licensed in Japan meant licensed in Australia," said Martin, who was previously a partner at law firm Allens.
This is some way off and would be a big step for the TGA as the radical part of the Japanese approach was how it turned conventional regulatory practice on its head.
Having missed the earlier antibody revolution (mainly around cancer drugs), Japan is betting big that regenerative medicine is the way of the future.
It aims to roughly halve the time it takes to commercials drugs.
This is done by licensing early stage technologies, which are proven safe, then giving them five to seven years to show they can have a meaningful health outcome.
Critics argued this could legalises inefficient treatments, but the Japanese saw the problem through a different lens and decided the cost of delaying true anti-aging therapies was greater than the risk of approving ineffective treatments.
"When Japan first did this it was considered radical and dangerous," said Martin.
"Now there is an emerging view that cell therapies will replace steroids for a wide range of inflammatory conditions."
This push to make Japan a world leader is being led by Abe himself, who has likened Japan's fight against ageing to the battle waged by the US against cholera in the 19th century.
"I will lead the efforts to carve out a new horizon for the latest medical technologies, including regenerative medicine and innovative drug development, through a streamlined system from research to practical application in which the public and private sectors work together," Abe told the Japan National Press club in April 2013, during a speech in which he laid out his vision for the country.
For Abe the push into regenerative medicine is part of the so called "third arrow" of Abenomics, which is aims to boost longer term growth through structural reform the first two arrows were monetary easing and fiscal consolidation.
As promised Abe did change the relevant laws in 2014 and the market has gradually come to see Japan as a world leader in regulating regenerative medicine.
But it lacks the early stage science of Australia, which is why it invited a local delegation to accompany the Trade Minister to Tokyo last week.
Now the question for Australia is whether it will allow its technologies to once again be licensed offshore and for Japan to receive much of the benefit or will take a bold step and follow Abe into the regenerative medicine revolution.
Link:
Japan's radical policy to fight ageing - The Australian Financial Review
With the right training and knowledge, many cyber attacks can be avoided. Addressing this human aspect of security is the idea behind a new platform from British start-up CybSafe.
Human error is a major cause of data breaches and security training needs to be able to positively change user behavior.
Using intelligent software and proprietary analytics, CybSafe's cloud-based platform learns an individual's knowledge level and their behavior patterns to deliver a personalized e-learning program. Delivered through a mobile app or online, the GCHQ-accredited e-learning platform is aimed at saving businesses money, not just by reducing their risk of falling victim to a security breach, but also by delivering meaningful training that constantly evolves based on current threats.
"Businesses recognize that their own staff represent their greatest security vulnerability, but its a problem that is costly and difficult to address and this results in cursory attempts to impart information which rarely has the desired effect," says Oz Alashe MBE, CEO and founder of CybSafe. "CybSafe transforms cyber awareness training from a box-ticking exercise into an immersive, recurring experience that positively changes security-related behavior."
The CybSafe platform is developed by specialists with a broad range of expertise. It uses written content combined with video learning and interactive assessments to make information accessible, maintain engagement and make learning effective.
Simulated cyber attacks are used to assess the level of effectiveness and retention of knowledge and there are regular updates based on the latest threat intelligence. There's a family and friends function too, so users can share the knowledge theyve gained.
Alashe adds, "Most businesses -- whether they have an information security team or not -- don't have the expertise, capacity or resource to address the human aspect of cyber security properly. The CybSafe platform gives them the edge and helps them more effectively protect their organization. We're harnessing the collective lessons from across the cyber security community and making this available to all."
You can find out more and sign up for a free trial on the CybSafe website.
Photo Credit: Wichy/Shutterstock
Read the original here:
New platform uses behavioral science to cut cyber security risks - BetaNews
CHICAGO I went to Morningstars panel on the latest techniques in behavioral finance for advisers with high hopes. But while the speakers made some strong points about psychological bias, they ignored the elephant in the room. Actually, make that about 150 elephants the advisers who attended the panel, along with fund managers and other financial professionals.
Investing is simple but not easy, according to Morningstar's Steve Wendel, the head of the firms behavioral science division. Learning about our biases helps clients become better investors, so advisers must be behavioral coaches to our clients.
During the presentation, Wendel referred to Russ Kinnel's work at Morningstar showing that investor returns lag fund returns due to poor timing. In other words, performance chasing.
Wendel made the case that advisers should help clients understand their behavior and get them prepared for the inevitable stock plunge. That can inoculate them from bad behavior, he says.
We advisers are people, too, and we must first control our own behavior.
Morningstar's Samantha Lamas, a client service associate, says she believes that tailoring advice to different generations is key. Retirement means something different to a 25-year old than a 60-year old client. They will likely have very different answers when asked where they want to be in 10 years. Thus, they will have different motivations.
But, I think the elephant in the room was completely ignored. We advisers are people, too, and we must first control our own behavior.
Years ago, I wrote how advisers were heavy in stocks on October 9, 2007, at the height of the real estate bubble and heavy in cash on March 9, 2009, at the bottom of the market. We timed bonds poorly because we were confident that tapering and ending Quantitative Easing would lead to rising rates. Rates declined significantly as bonds rallied.
Perhaps we should take a painful look at the advice each of us gave clients at that time, to see if we timed markets poorly. What role did our own biases play in our portfolio decisions? Don't assume it was those other advisers who behaved badly. No market plunge or surge should go wasted. We are kidding ourselves if we think we can inoculate ourselves, or our clients, from the pain of a market plunge. The best we can do is work through the pain and buy stocks when the herd is selling. That is truly simple but not easy.
If we use behavioral finance to acquire clients, it will surely backfire. But if we use it to help clients, we may find those clients become fans who refer other clients.
Allan S. Roth, a Financial Planning contributing writer, is founder of the planning firm Wealth Logic in Colorado Springs, Colorado. He also writes for The Wall Street and AARP The Magazine and has taught investing at three universities. Follow him on Twitter at @Dull_Investing.
Read more from the original source:
Ignoring elephants in the room at Morningstar behavioral finance panel - Financial Planning
Kimberly-Clark Professional has launched an industrial cloth and a system that uses behavioural science to improve worker hand hygiene.
The Kimtech Precision Cleaning Cloths and Allergen Control and the Continuum System were unveiled at the Global Food Safety Conference in Houston, Texas.
The disposable cloth, designed to remove allergens from food contact surfaces, will be launched in Latin America first and to the rest of the world by the end of the year.
It works on surfaces such as stainless steel and those that have direct contact with food like the inside of equipment and conveyor belts.
Basic principles of cleaning
Phillip Jarpa, global segment marketing manager of food processing at Kimberly-Clark Professional, said it is primarily for controlled wet type of cleaning usually found in dry environments.
The reason being that is where most of the clean out of place happens so you usually apply force and we know that those types of industries are focussed on controlling as much as they can the presence of moisture. So the cloths are not only good at removing but also helping drying those surfaces and preventing moisture, he told FoodQualityNews at the event.
This is important because removing allergens is about not just separating but also removing from surfaces and to avoid redeposit. We were able to remove up to 100% of some of the most unwanted allergens by combining with water.
This cloth is meant to be integrated in the current process without affecting product changeover time, for example. It is not a new step for dry processing environments it is replacing some of the supplies they are using so there should be no impact on cleaning time. We are not thinking about high volume because these are usually very precise tasks.
Jarpa said allergens are a new threat for industry which it is at the beginning stage of handling.
Regulation has moved faster than the practices. What the industry is using today is old technology for new contamination threats. It is very common to use brushes and vacuums which are very good at separating but not very good at removing and preventing from redepositing, he said.
This product falls under cleaning when manual force is applied under the controlled wet and drying process so the amount to be used is going to depend on the surface and the complexity of the soil.
Hand hygiene is important but is considered as basic and not a priority, according to Jarpa.
When you look at some of the research done, for example in a meta-analysis that looked at 66 outbreaks in the US in 23 years, they discovered around 82% were caused by workers and 50% of those, hands were the source of transmission. Which is not a surprise, when you see that 50% of employees do not wash their hands for the right amount of time, he said.
Other research has shown when you dont wash your hands for at least 20 seconds you wont effectively remove bacteria like E. coli and Shigella. When you go to the behavioural part, we know moist hands can proliferate bacteria 1,000 times more than dry hands.
Imagine you are a food worker and you have wet hands and you look across and you have 20 people in line for their turn at the hairdryer and youre standing there and you think Im not even paid for this, Im paid for being inside there. So what are they going to do? They are going to rub it on their apron which is the number one concern for QA managers when it comes to the hygiene station.
It is common practice that dryness in the hand hygiene process is overlooked and that causes bacterial proliferation and skin irritation of workers, said Jarpa.
If they are going to don gloves that is just a petri-dish effect. They can wear gloves; the problem is if your hands are dirty or moist when gloves rupture, as they rupture all the time, a single pinhole can release thousands of bacteria. We have seen many companies move away from gloves as they realise gloves make employees not care or worry about hand hygiene.
So those are the hands that are touching our food, that will go onto our surfaces but because traceability of an event to hand hygiene is so hard unless you make it visual and you provide industry with this data it wont be taken seriously.
The human factor
The Continuum System understands people are the most complex element of a process, said Jarpa.
There are a lot of existing models on behavioural science and Kimberly-Clark has experts on the subject, he added.
For example, the Kimtech cloth is part of this system. Weve incorporated the principles of behavioral science on the design of the product itself, how it will be used, where will it be used, what would workers be primed to, but we support that with interventions which are simple disruptive ideas that will drive behavior change for cleaning and for hygiene.
We start with the walk the walk is on-site where we look at practices, what are workers doing when it comes to hygiene and cleaning; station design so where and what are they doing it with and as an outcome of that well make a preliminary report on how effective the combination of those two things are today and how we can help them through products and interventions.
Weve done this in more than eight countries, for example in a facility in Latin America we were able to reduce dirty [more than 1,000 cfu/g per hand] from being 55% of the plant to being 3% of the plant without training a single employee, just by understanding what drives them.
For hand hygiene, washing and drying under Continuum the product brand will be Scott and for cleaning it will be Kimtech.
Food safety culture risks becoming a trend word, said Jarpa.
We have worked with GFSI member companies and based on what they are doing and public research we have defined a food safety culture as a place where you are guided by norms, so where safety is what you do and not what you are told, where safety is a value and not a priority; difference being that priorities change.
Jarpa said there are at least five dimensions of what need to be covered.
Continuum describes all the stages you will go through to get to that ideal within those five dimensions. One of the key ones, which is around norms, is practices so what is being done today? So that is why we start with behavior of employees. If we understand what it is they are doing and why they are doing it, it will be easier to move that dimension, he said.
In leadership what are the basic tools and processes that we can help our customers do to ignite change and sustain it. Engagement and motivation has a lot to do with how we address their workers.
One of the last dimensions, which is a joint effort, is how do we communicate and benchmark those practices. So we benchmark the different walks that we do so customers can see how they compare to the industry average of every other facility we have gone through and that way they have measurable baselines that they can act upon.
See the original post here:
Kimberly-Clark Professional addresses allergens and hand hygiene - FoodQualityNews.com
medAge is customized medicine using a team approach to help patients become healthier and more energetic.
medAge patients lose fat and are leaner.They have lower risks for heart disease, cancer, arthritis, bone loss and other chronic conditions frequently associated with aging and the typical American lifestyle.
These are conditions that are commonly diagnosed and treated but rarely prevented in many medical offices. medAge is also anti-aging medicine staying abreast of the science to help patients stay healthy and look and feel young. medAge was founded in Asheville, a mecca for health and wellness centers. Due to its success at identifying and reversing early stages of disease,medAge can now be found in other parts of the country.
How medAge is different from other medical practices:
medAge is scientifically sound medicine and helps each individual patient formulate a healthy, sustainable way of living which is enjoyable and tailored to their specific lifestyle.
A division of medAge is dedicated to professional and amateur athletes of all ages. medAge for Athletes uses precise biometric measurements to test and train athletes allowing them to achieve peak performance in their individual sport. medAge trained athletes can be found all over the world competing and excelling in professional sports.
For more information on how to achieve optimal health visit http://www.medage.com.
Here is the original post:
Achieve a lifetime of good health with care at medAge - The Mountaineer
Whats going on in Eastgate Biotech Corp (OTCMKTS:ETBI) sharesis any ones guess, and any time you see a stock move 150% or more you must ask the question. I see (by looking at the technical picture in a chart below) that this is a stock that made a high volume low and turning out of triple sub penny status and are retracing losses from early April.
When a stock trades 65 million shares something is up. It goes back to the volume strategy all sub penny traders must adhere to in terms of the volume growth ramp driving prices higher. The presence of new money in the stock has been a consistent theme with many movers we write about. Be aware that you must pay attention when this volume begins to decline, because when the music stops (and it always does), shares can have unwanted downside volatility.
Eastgate Biotech Corp(OTCMKTS:ETBI) is an emerging pharmaceutical stock that produces and distributes innovative and healthy nutraceuticals based on natural therapies as well as focusing on new pharmaceutical developments. The driver revolves around its recent acquisition, OMNI Surgery and Anti-Aging Centre has appointed a new Medical Director.Dr. Ishaan Sundar has assumed the role of Medical Director effective immediately. Educated by the American Academy of Aesthetic Medicine, American Cosmetic Cellular Medicine Association, Laser Sheer Training Academy and trained in Injectable Placements, Dr. Sundar brings over 20 years of extensive practice to the OMNI state-of-the-art centre.With a distinguished career in Critical Care Medicine (ICU, CCU), Dr. Sundar will oversee medical and surgical operations at Saskatchewans only combined fee-for-service surgical and anti-aging centre.
OMNI Surgery and Anti-Aging Centre is an upscale facility serving an underserved market in Regina, Saskatchewan, Canada with great growth potential. It is poised to participate in the growing anti-aging market.According to Transparency Market Research, the Global Anti-Aging Market Boosted by Baby Boomer Population nearing retirement is to be worth US$191.7 Billion by 2019.
We are thrilled to welcome an experienced physician like Dr. Sundar to our leadership team.His holistic approach of crafting treatment plans unique to each individual mirrors OMNIs mission of making our patients feel comfortable and at ease, while getting the results that they want, states Bill Abajian, Global Business Development and Licensing at EastGate and former owner of OMNI Surgery.
Find outwhen $ETBI stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
OMNI is a fee-for-service, Surgery + Anti-Aging Centre offering plastic, orthopaedic, along with general surgical procedures. Alongside the surgical procedures, the Anti-Aging Centre is equipped with State-of-the-Art technology that work to contour, tone, and remove blemishes in order to reverse the aging process. As a Centre of Excellence in Saskatchewan, OMNIs board-certified surgeons work to deliver high quality care mindful of patients needs, while helping them achieve the results they want.
EastGate Biotech Corp. (OTCMKTS:ETBI) produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. But the real question here is about how shares will trade over the coming weeks and any retest of the lows on higher volume would be bad, on the upside you need to retrace the decline and test .03 cents which is another big leg higher for ETBIstock.
This would be easy to track by observing the volume alone, the short term players are here, now you need to sort out the meaning of these volume clues they translate to price so often it emerges as the most important metric to watch on any trading day.For more news on $ETBIand other fast-moving penny stocks, please subscribe to OracleDispatch.com below.
More:
What's Going On With Eastgate Biotech Corp (OTCMKTS:ETBI) - The Oracle Dispatch
NEW YORK, NY--(Marketwired - April 25, 2017) - When it comes to cybersecurity, you are the weakest link, according to insights uncovered by non-profit behavioral design lab ideas42. That holds true from the workplace to your home, from your personal banking data to your employer's systems and records.
Despite public and private sector investments in sophisticated security systems, vulnerabilities remain. This is due in part to the fact that the search for answers has been heavily steered toward finding technological solutions alone. In reality, up to 80% of the cost attributed to cyber attacks is actually a result of human error -- or, rather, human behavior.
In the final installment of Deep Thought, a CyberSecurity Story, released today, ideas42 addresses this technical problem in a way most people can relate to -- through a story. The true-crime novella dramatizes the human factors in cybersecurity and includes a robust index of key insights from behavioral science that can be used to rethink and improve security protocols.
Drawing on insights revealed in the story, here are five reasons you are the biggest threat to America's cybersecurity:
1. You connect to public Wi-Fi everywhere you go. Remember when connecting to an insecure, public Wi-Fi network: if it's easy for you, it's probably easy for "the bad guy."
2. Security warnings have lost all meaning to you. The "habituation" effect -- when we get used to something after seeing it several times -- often causes you to disregard security warnings with a single click, even if they are legitimate.
3. You think (and click) way too fast. Thinking fast can get you into trouble in a variety of situations, but it's particularly dangerous online, when one small action-opening a bad email or clicking the wrong link-can have a high cost. Is that weird email just a weird email, or is it a phishing attempt?
4. You don't follow through on installing the updates your device wants you to install. Poor "choice architecture" -- for instance, how a website or digital procedure is structured -- can often lead you to defer important security steps like downloading a new security patch or updating your operating system in a timely way.
5. Your pet's name is your password. When it comes to creating passwords, it is randomness (not your pet's name) that is your friend. Yet common security "rules of thumb" often inadvertently lead you in the opposite direction and result in passwords that hackers can work out in seconds.
This list isn't comprehensive -- it merely underscores the real problem with cybersecurity. The most secure system in the world is only as strong as the humans interacting with it. Failing to design for how we as human beings actually behave creates the opening for security breaches of all kinds.
Aside from tips like these, the ideas42 novella includes a rich vein of behaviorally-informed insights that can help organizations design systems that work with our human tendencies, not against them. The goal is to focus on behavioral insights and solutions that can be adopted quickly and brought to scale. For a full copy of the novella and behavioral insight appendix visit ideas42.org/cyber.
Here is our ideas42 novella and our cybersecurity video.
The organization's work in cybersecurity is supported by the William and Flora Hewlett Foundation Cyber Initiative in partnership with New America's Cybersecurity Initiative.
About ideas42
At ideas42 we believe that a deep understanding of human behavior will help us improve millions of lives. Using insights from behavioral science, we create innovative solutions in economic mobility, health, education, criminal justice, consumer finance, energy efficiency and international development. We're a nonprofit with more than 80 active projects in the United States and around the world and many partnerships across governments, foundations, NGOs and corporations.
Excerpt from:
ideas42: The biggest threat to America's cybersecurity is YOU - Yahoo Finance